Optimizing Stroke Prophylaxis of Acute Atrial Fibrillation With an Electronic Clinical Decision Support Tool
NCT05341986 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36
Last updated 2025-03-20
Summary
Atrial fibrillation (AF) is the most common arrhythmia in the world, with significant morbidity and mortality. With appropriate oral anticoagulation, the risk of stroke due to atrial fibrillation decreases by 64%. Although atrial fibrillation is commonly diagnosed and treated in the Emergency Department (ED), oral anticoagulation is significantly underprescribed. Underprescribing has been attributed to a lack of empowerment and deferral of prescribing to longitudinal care clinicians.
Using a convergent parallel quantitative-qualitative design (mixed-methods), we propose a stepped-wedge cluster randomized trial design with the implementation of a clinical decision support (CDS) tool in adults with new-onset AF that are OAC-naïve and at significant risk for stroke. In parallel, we will use qualitative approaches to evaluate clinician facilitators and barriers to tool utilization as well as patient satisfaction and engagement with the tool.
Conditions
Interventions
- OTHER
-
Clinical Decision Support (CDS) tool
Implementation of an EHR-based CDS tool for providers to use.
Sponsors & Collaborators
-
Oregon Health and Science University
lead OTHER
Principal Investigators
-
Bory Kea, MD, MCR · Oregon Health and Science University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-01-11
- Primary Completion
- 2026-03-01
- Completion
- 2026-05-01
Countries
- United States
Study Locations
More Related Trials
-
Electronic Alerts for Stroke Prevention in Patients With Atrial Fibrillation or Atrial Flutter
NCT02339493 ·Status: COMPLETED ·Phase: NA
-
EHR-Embedded Decision Support to Prevent Stroke in Patients With AF
NCT04099485 ·Status: COMPLETED ·Phase: NA
-
Supporting Use of AC Through Provider Profiling of Oral AC Therapy for AF
NCT03583008 ·Status: COMPLETED ·Phase: NA
-
Rhythm Evaluation for AntiCoagulaTion With COntinuous Monitoring
NCT01706146 ·Status: COMPLETED ·Phase: PHASE4
-
Secondary Prevention of Atrial Fibrilation
NCT03259893 ·Status: TERMINATED ·Phase: NA
-
Efficacy of Aldosterone Antagonist Therapy for Prevention of New Atrial Fibrillation
NCT03929718 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Supporting Use of AC Through Provider Profiling of Oral AC Therapy for AF IV
NCT05236556 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Atrial Fibrillation Incidence, Risk Factors and Genetics
NCT00021905 ·Status: COMPLETED
-
Application of "I-Anticoagulation"in Patients With Atrial Fibrillation
NCT06137794 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Stroke Risk Assessment and Markers of Blood Clotting in Patients With Newly Diagnosed Non-valvular Atrial Fibrillation (NVAF), Who Have Not Received Oral Anticoagulation Therapy (OAC-therapy) Prior to Inclusion
NCT06949319 ·Status: RECRUITING
-
A Study to Quantify Use of Anticoagulation to Improve Management of Atrial Fibrillation
NCT03382613 ·Status: TERMINATED
-
RAPID AFib Decision Aid for Stroke Prevention in Atrial Fibrillation
NCT05900414 ·Status: RECRUITING ·Phase: NA
-
Responding to AF: Pill-in-Pocket Anticoagulation Guided by Automated Monitoring and Alerts
NCT06922695 ·Status: RECRUITING ·Phase: NA
-
Boston Scientific's Cryoballoon in the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation
NCT04133168 ·Status: COMPLETED ·Phase: NA
-
Evaluation the Effectiveness of the Risk Minimisation Activities in the Treatment of Stroke Prevention in Atrial Fibrillation
NCT02433366 ·Status: COMPLETED
-
Intravenous Cardioversion of Atrial Fibrillation (AF) With AZD1305
NCT00915356 ·Status: COMPLETED ·Phase: PHASE2
-
Mhealth Application for anTicoagulation Care in Atrial Fibrillation
NCT03174093 ·Status: UNKNOWN ·Phase: NA
-
Electronic Alerts for Stroke Prevention in Atrial Fibrillation
NCT02958943 ·Status: COMPLETED ·Phase: NA
-
Shared Decision Making to Address Racial Disparities in Oral Anticoagulation in NVAF
NCT04956978 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
A Study to Assess the Effectiveness of an Atrial Fibrillation (AF) Risk Prediction Algorithm and Diagnostic Test in Identifying Patients With AF.
NCT04045639 ·Status: COMPLETED
-
Patient Perceptions and Physician Assessment of Benefits and Risks of Oral Anticoagulation Due to Non-valvular AF
NCT03061123 ·Status: COMPLETED
-
E-learning to Improve Oral Anticoagulant Use in Hospitalized Older People With AF
NCT03188211 ·Status: COMPLETED ·Phase: NA
-
Understanding and Improving Anticoagulation Dosing for Patients With Atrial Fibrillation
NCT03719144 ·Status: COMPLETED
-
Study of RSD1235 to Evaluate Safety in Patients With Atrial Fibrillation
NCT00281554 ·Status: COMPLETED ·Phase: PHASE3
-
Assessing the Neurological Outcomes After Atrial Fibrillation Ablation for Rhythm Control
NCT06783868 ·Status: NOT_YET_RECRUITING